USMI to Debut Canady Robotic AI Surgery at Global Oncology Summit - Jerusalem, January 2024
Saturday, September 23, 2023
The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are delighted to announce a groundbreaking achievement in the realm of surgical and robotic technology. They have developed the Canady Robotic AI Surgical System, a pioneering innovation that represents the world's first AI robotic system capable of delivering cold atmospheric plasma (CAP), a three-dimensional, non-contact bioelectric pulse electromagnetic field. This remarkable technology selectively targets and eliminates microscopic tumor cells during surgery while safeguarding the surrounding healthy tissue. Despite significant progress in surgical techniques and various cancer treatment modalities such as chemotherapy, radiation therapy, immunotherapy, and biologic targeted therapy, there has remained a persistent challenge of microscopic residual disease, which can range from 5% to 65%. This contributes to local regional recurrence and reduced survival rates.
The Canady Robotic AI Surgical System will be unveiled at the inaugural Global Surgical Oncology Summit in Jerusalem, Israel, taking place from January 30 to February 2, 2024. Key components of the system include a Motorized Positioning Arm, the ORLI™ (Speech Recognition Canady Electrosurgical Generator), a Controller for CAP Devices, and Robotic Assisted End Effectors suitable for a wide range of surgical procedures, including Open, Laparoscopic, Thoracoscopic, Endoscopic, and Mini-invasive surgeries. The system offers the surgeon 10 degrees of freedom, voice-activated robotic movements, AI-powered software programs, 3D Navigational Guided Surgical Planning, advanced CAP Beam Contour Tracking, pre-programmed CAP Dosimetry data for targeting 32 different types of cancer cells, and a compact, mobile design, making it a truly groundbreaking advancement in surgical technology.
This innovative technology has the potential to revolutionize operating rooms worldwide, with ORLI™ serving as a user-friendly control system for the integrated SMART Operating Room. Comparable to popular virtual assistants like SIRI, ALEXA, and GOOGLE HOME, ORLI™ is designed specifically for the operating room environment. Data from a recent FDA Phase 1 Clinical Trial conducted on Stage 4 Cancer Patients, combined with a decade's worth of translational molecular research, has been seamlessly incorporated into the Canady Robotic AI Surgical System. This achievement represents a monumental leap forward in the integration of artificial intelligence and robotics in the field of surgery.